SFBS:NYSEServisFirst Bancshares, Inc. Analysis
Data as of 2026-04-30 - not real-time
$78.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ServisFirst Bancshares (SFBS) is trading at $78.26, just above its 20‑day (77.53) and 50‑day (77.40) simple moving averages and marginally above the 200‑day SMA (78.20), indicating short‑term momentum. The MACD histogram is positive (0.22) with a bullish signal, while the RSI of 52.8 suggests the stock is neither overbought nor oversold. Recent Q1 2026 results delivered a 20.6% year‑over‑year revenue rise to $159 M and an EPS of $1.52, slightly beating consensus estimates, reinforcing earnings momentum.
Valuation appears attractive: a trailing P/E of 14.44 versus the industry average of 17.51 and a forward P/E of 10.92 signal undervaluation. The dividend yield of 1.94% with a modest 26% payout ratio looks sustainable given a cash pile (~$1.84 B) that comfortably exceeds total debt (~$1.58 B). An upside potential of roughly 20.5% toward the consensus target price of $94‑95 further enhances the case.
Valuation appears attractive: a trailing P/E of 14.44 versus the industry average of 17.51 and a forward P/E of 10.92 signal undervaluation. The dividend yield of 1.94% with a modest 26% payout ratio looks sustainable given a cash pile (~$1.84 B) that comfortably exceeds total debt (~$1.58 B). An upside potential of roughly 20.5% toward the consensus target price of $94‑95 further enhances the case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Stable volume and neutral trend direction
- Recent earnings beat and modest upside to target
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (18.5% YoY) and EPS expansion
- Undervalued relative to industry P/E multiples
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust cash position exceeding debt obligations
- Consistent profitability and solid ROE (16.5%)
- Regional market exposure with growth opportunities in the Southeast
Key Metrics & Analysis
Financial Health
Revenue Growth18.50%
Profit Margin53.99%
P/E Ratio14.4
ROE16.55%
ROA1.61%
P/B Ratio2.3
Industry P/E17.5
Technical Analysis
TrendNeutral
RSI52.8
Support$71.76
Resistance$80.94
MA 20$77.53
MA 50$77.40
MA 200$78.20
MACDBullish
VolumeStable
Fear & Greed Index88.48
Valuation
Target Price$94.33
Upside/Downside20.54%
GradeUndervalued
TypeBlend
Dividend Yield1.94%
Risk Assessment
Beta1.24
Volatility23.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.